Parkinson's disease and enhanced inflammatory response

被引：126
|
作者：
Stojkovska, Iva [1 ]
Wagner, Brandon M. [1 ]
Morrison, Brad E. [1 ]
机构：
[1] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2015年 / 240卷 / 11期
关键词：
Parkinson's disease; neuroinflammation; inflammation; disease models; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-BRAIN-BARRIER; SYNUCLEIN TRANSGENIC MICE; ALPHA-SYNUCLEIN; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; MITOCHONDRIAL DYSFUNCTION; INTRANIGRAL INJECTION; INTERFERON-GAMMA;
D O I：
10.1177/1535370215576313
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Parkinson's disease (PD) is the first and second most prevalent motor and neurodegenerative disease, respectively. The clinical symptoms of PD result from a loss of midbrain dopaminergic (DA) neurons. However, the molecular cause of DA neuron loss remains elusive. Mounting evidence implicates enhanced inflammatory response in the development and progression of PD pathology. This review examines current research connecting PD and inflammatory response.
引用
收藏
页码：1387 / 1395
页数：9
相关论文
共 50 条
  • [11] The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
    White, Alice J.
    Wijeyekoon, Ruwani S.
    Scott, Kirsten M.
    Gunawardana, Nushan P.
    Hayat, Shaista
    Solim, I. H.
    McMahon, H. T.
    Barker, Roger A.
    Williams-Gray, Caroline H.
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [12] Effect of Wuzi Yanzong pill on inflammatory response in Parkinson's disease mouse
    Chai, Z.
    Fan, H. J.
    Ll, Y. R.
    Sun, M. Y.
    Yu, J. Z.
    Li, Y. H.
    Zhang, B.
    Jin, X. M.
    Xaio, B. G.
    Ma, C. G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1925 - 1926
  • [13] Inflammatory bowel disease and risk of Parkinson's disease
    Pinel-Rios, Javier
    Javier Madrid-Navarro, Carlos
    Jose Perez-Navarro, Maria
    Campos-Arillo, Victor
    Minguez-Castellanos, Adolfo
    Escamilla-Sevilla, Francisco
    PARKINSONISM & RELATED DISORDERS, 2018, 57 : 78 - 79
  • [14] Inflammatory Animal Models of Parkinson's Disease
    Garcia-Revilla, Juan
    Herrera, Antonio J.
    de Pablos, Rocio M.
    Luis Venero, Jose
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 : S165 - S182
  • [15] Inflammatory Bowel Diseases and Parkinson's Disease
    Brudek, Tomasz
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 : S331 - S344
  • [16] Oxidative and Inflammatory Pathways in Parkinson’s Disease
    Rebecca L. Miller
    Marilyn James-Kracke
    Grace Y. Sun
    Albert Y. Sun
    Neurochemical Research, 2009, 34 : 55 - 65
  • [17] PARKINSON'S DISEASE: IS IT ACTUALLY AN INFLAMMATORY DISORDER?
    Buyukkoyuncu Pekel, Nilufer
    Yildiz, Demet
    Sigirli, Deniz
    Yabaci, Aysegul
    Seferoglu, Meral
    Gunes, Aygul
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2018, 21 (04): : 483 - 489
  • [18] Serum inflammatory biomarkers in Parkinson's disease
    Dufek, M.
    Hamanova, M.
    Lokaj, J.
    Michalkova, Z.
    Rektorova, I.
    Goldemund, D.
    Rektor, I.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S293 - S294
  • [19] Serum inflammatory biomarkers in Parkinson's disease
    Dufek, M.
    Hamanova, M.
    Lokaj, J.
    Goldemund, D.
    Rektorova, I.
    Michalkova, Z.
    Sheardova, K.
    Rektor, I.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (04) : 318 - 320
  • [20] Serum inflammatory biomarkers in Parkinson's disease
    Rektor, I.
    Dufek, M.
    Lokaj, J.
    Hamanova, M.
    Goldemund, D.
    Rektorova, I.
    Michalkova, Z.
    Sheardova, K.
    MOVEMENT DISORDERS, 2008, 23 (01) : S323 - S323
12345